A NEW APPLICATION FOR LIPOSOMES IN CANCER-THERAPY - IMMUNOLIPOSOMES BEARING ENZYMES (IMMUNO-ENZYMOSOMES) FOR SITE-SPECIFIC ACTIVATION OF PRODRUGS

被引:41
作者
VINGERHOEDS, MH [1 ]
HAISMA, HJ [1 ]
VANMUIJEN, M [1 ]
VANDERIJT, RBJ [1 ]
CROMMELIN, DJA [1 ]
STORM, G [1 ]
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT MED ONCOL,AMSTERDAM,NETHERLANDS
关键词
MONOCLONAL ANTIBODY; LIPOSOME; ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY; ADEPT; TARGETED DRUG DELIVERY;
D O I
10.1016/0014-5793(93)80861-N
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have tested a new type of immunoliposomes which may effectively mediate the targeting of enzymes to be used for site-specific prodrug activation (immuno-enzymosomes). The enzyme beta-glucuronidase, capable of activating the prodrug epirubicin-glucuronide (epi-glu), was coupled to the external surface of immunoliposomes directed towards ovarian cancer cells. A significant increase in cytotoxicity of the prodrug epi-glu was shown when the in vitro cultured cancer cells were pretreated with these immuno-enzymosomes.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 30 条
[1]   IMMUNOLOGICAL ASPECTS OF LIPOSOMES - PRESENTATION AND PROCESSING OF LIPOSOMAL PROTEIN AND PHOSPHOLIPID ANTIGENS [J].
ALVING, CR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1113 (3-4) :307-322
[2]   A CYTO-TOXIC AGENT CAN BE GENERATED SELECTIVELY AT CANCER SITES [J].
BAGSHAWE, KD ;
SPRINGER, CJ ;
SEARLE, F ;
ANTONIW, P ;
SHARMA, SK ;
MELTON, RG ;
SHERWOOD, RF .
BRITISH JOURNAL OF CANCER, 1988, 58 (06) :700-703
[3]  
CONNOR J, 1986, CANCER RES, V46, P3431
[4]  
Dutton G. J., 1966, GLUCURONIC ACID FREE
[5]   CELLULAR GENES ANALOGOUS TO RETROVIRAL ONC GENES ARE TRANSCRIBED IN HUMAN-TUMOR CELLS [J].
EVA, A ;
ROBBINS, KC ;
ANDERSEN, PR ;
SRINIVASAN, A ;
TRONICK, SR ;
REDDY, EP ;
ELLMORE, NW ;
GALEN, AT ;
LAUTENBERGER, JA ;
PAPAS, TS ;
WESTIN, EH ;
WONGSTAAL, F ;
GALLO, RC ;
AARONSON, SA .
NATURE, 1982, 295 (5845) :116-119
[6]  
FISHMAN WH, 1970, METABOLIC CONJUGATIO
[7]  
Fiske CH, 1925, J BIOL CHEM, V66, P375
[8]   A MONOCLONAL ANTIBODY-BETA-GLUCURONIDASE CONJUGATE AS ACTIVATOR OF THE PRODRUG EPIRUBICIN-GLUCURONIDE FOR SPECIFIC TREATMENT OF CANCER [J].
HAISMA, HJ ;
BOVEN, E ;
VANMUIJEN, M ;
DEJONG, J ;
VANDERVIJGH, WJF ;
PINEDO, HM .
BRITISH JOURNAL OF CANCER, 1992, 66 (03) :474-478
[9]  
HAMILTON TC, 1983, CANCER RES, V43, P5379
[10]   TARGET-SENSITIVE IMMUNOLIPOSOMES - PREPARATION AND CHARACTERIZATION [J].
HO, RJY ;
ROUSE, BT ;
HUANG, L .
BIOCHEMISTRY, 1986, 25 (19) :5500-5506